YM BIOSCIENCES ANNOUNCES POSITIVE PRELIMINARY RESULTS FROM PHASE I …CNNMoney.com - Sep 4, 2007Nimotuzumab has been sub-licensed by CIMYM to Daiichi Sankyo Co., Ltd for Japan, Oncoscience AG in Europe, Kuhnil Pharmaceutical Co. in South Korea and …
Read full story
Dow AgroSciences and Exelixis Plant Sciences Announce Major …CNNMoney.com - 20 hours ago… pharmaceutical and biotechnology companies, including GlaxoSmithKline, Bristol-Myers Squibb Company, Genentech, Wyeth Pharmaceuticals and Daiichi-Sankyo …
Read full story
Nebivolol Lowers Blood Pressure in Mild-to-Moderate Hypertensive …CNNMoney.com - Sep 4, 2007Forest Laboratories is a US-based pharmaceutical company dedicated to identifying, developing, and delivering products that make a positive difference in …
Read full story
Exelixis Reports Encouraging Interim Data From a Phase 2 Trial of …CNNMoney.com - 16 hours ago… pharmaceutical and biotechnology companies, including GlaxoSmithKline, Bristol-Myers Squibb Company, Genentech, Wyeth Pharmaceuticals and Daiichi-Sankyo …
Read full story
Daiichi Sankyo and Forest Laboratories Sign Letter of Intent for …CNNMoney.com - Aug 21, 2007Daiichi Sankyo, Inc., headquartered in Parsippany, New Jersey, is the US subsidiary of Daiichi Sankyo Co., Ltd., Japan's second largest pharmaceutical …
Read full story
YM BioSciences USA cleared by US FDA to initiate Phase II clinical …CNNMoney.com - Aug 30, 2007Nimotuzumab has been sub-licensed by CIMYM to Daiichi Sankyo Co., Ltd for Japan, Oncoscience AG in Europe, Kuhnil Pharmaceutical Co. in South Korea and …
Read full story
Exelixis Announces September 5 Webcast of Its 2007 IASLC Investor …CNNMoney.com - Aug 29, 2007… pharmaceutical and biotechnology companies, including GlaxoSmithKline, Bristol-Myers Squibb Company, Genentech, Wyeth Pharmaceuticals and Daiichi-Sankyo …
Read full story
Out of the Gate: Forest Laboratories UpForbes, NY - Aug 22, 2007Daiichi Sankyo is a unit of Japanese pharmaceutical company Daiichi Sankyo Co. The companies expect the US Food and Drug Administration to rule on their …
Read full story
Forest Labs to co-promote blood pressure drugCrain’s New York Business, NY - Aug 21, 2007Under the six year deal, Daiichi Sankyo, a Parsippany, NJ-based joint venture of the Tokyo-based firms Daiichi Pharmaceutical Co. and Sankyo Co., …
Read full story
Partnership for Prescription Assistance offers helpNewport News Times, OR - Aug 29, 2007Also Eisai Inc., Eli Lilly and Company, EMD Serono Inc., Saizen, Endo Pharmaceuticals Inc., Faulding Pharmaceuticals Inc., First Horizon Pharmaceutical …
Read full story
Additional Pediatric Indication for Fentanyl Injection ApprovedPharmaLive.com (press release), PA - Aug 28, 2007TOKYO, August 28 , 2007 – DAIICHI SANKYO COMPANY, LIMITED announced today that its Group company DAIICHI SANKYO PROPHARMA Co., LTD. …
Read full story
Research and Markets: Daiichi Sankyo IMS Company Profile Gives an …Business Wire (press release), CA - Aug 10, 2007Each individual IMS Company Profile analyzes the critical components that make up a pharmaceutical company, providing you with a clear assessment of the …
Read full story
GlaxoSmithKline Accelerates Review of Exelixis' XL880CNNMoney.com - Aug 23, 2007… Genentech, Wyeth Pharmaceuticals and Daiichi-Sankyo. For more information, please visit the company's web site at http://www.exelixis.com. …
Read full story
Focus on the Imaging Agents Market - Contrast Media (X-Ray, MRI …Genetic Engineering News (press release), NY - Aug 28, 2007… Alliance Pharmaceutical Corp., Amersham PLC, Biomira, Inc., Bracco Group, Bristol-Myers Squibb, Cytogen Corp., Daiichi Sankyo Company Limited, …Daiichi Pharmaceutical Co - Google News
Read full story
Daiichi Sankyo Leases US HQ in ParsippanyCoStar Group, MD - Aug 8, 2007Diane Chayes represented Mack-Cali in-house. Daiichi Sankyo Inc. is the US subsidiary of Daiichi Sankyo Co. Ltd., Japan's second largest pharmaceutical …
Read full story
Antibiotic Resistance and Generic Competition Impede Antibiotics …PR-GB.com (press release), Bulgaria - Aug 7, 2007… Pharmaceutical Corp., Bayer HealthCare AG, Cubist Pharmaceuticals, Inc., Daiichi Sankyo Company Limited, Eli Lilly and Co., Kyorin Pharmaceutical Co., …
Read full story
ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES …CNNMoney.com - Aug 15, 2007Nimotuzumab has been sub-licensed by CIMYM to Daiichi Sankyo Co., Ltd for Japan, Oncoscience AG in Europe, Kuhnil Pharmaceutical Co. in South Korea and …
Read full story
Japan Outlook: Hitachi, Mazda, NEC, Tepco 1Q; June JoblessFXstreet.com The Foreign Exchange Market, Spain - Jul 30, 2007CORPORATE EVENTS 0600 Chugai Pharmaceutical Co. (4519.TO) reports earnings for the fiscal first half. 0200 - Teijin Ltd. (3401.TO) - Fuji Heavy Industries …
Read full story
REFILE-UPDATE 3-Takeda profit rises 5 percent, outlook unchangedReuters - Jul 31, 2007Full Bio By Edwina Gibbs TOKYO, July 31 (Reuters) - Takeda Pharmaceutical Co. Ltd. (4502.T: Quote, NEWS , Research) said quarterly profit rose 5 percent but …
Read full story
Top Products Help ProfitWall Street Journal - Jul 31, 2007Daiichi Sankyo Co., Japan's second-largest pharmaceutical maker, posted a 14% drop in net profit to 41.41 billion yen from 48 billion yen a year earlier. …UPDATE 2-Takeda profit rises 5 percent, outlook unchanged Reutersall 41 news articles
Read full story